chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: M
Vaccine: MEN, MMR, SMALL, TD
Symptoms: Pharyngeal oedema, Pyrexia, Skin ulcer, Vaccination complication
Clinical narrative: The military inoculated me with the smallpox vaccine during basic training, in that I had a reaction to, and become infected with Eczema vaccinatum while serving on active duty on/or about May 18, 1989. The initial reaction occurred three days later - I had  swelling of the throat and passed out or became unconscious.  I had fever and was not conscious for about 3 days after the initial reaction. I broke out with about 75 to 100 sores over my neck, shoulders, face, and scalp area. I was in ICU isolation for over 6 weeks and almost died. They used an "unknown test drug" that was under investigation at the time to expedite the healing. Each time the gauze was changed on my face, I had to put my face in a "downward position" due to the pus dripping everywhere, causing a horrible mess. I have permanent scarring all around my face and will never forget the horrific pain of the huge blisters. This has caused me permanent and ongoing immune problems as well as neurological damage in my brain. From the smallpox, a string of health conditions evolved while on duty.
Age: 50.0
Sex: M
Vaccine: FLU3, TYP, FLUX, TYP
Symptoms: Face oedema, Hypoaesthesia, Pain, Speech disorder
Clinical narrative: Chief complaint of right arm numbness, pain, difficulty speaking, asymmetry of lips at 2:30 in the afternoon following a vaccination of Influenza and Typhoid at 11:30am.  Patient was taken to hospital by EMS.
Age: 50.0
Sex: M
Vaccine: FLU3, TYP, FLUX, TYP
Symptoms: Coordination abnormal, Dizziness, Dysarthria, Fatigue, Injection site reaction
Clinical narrative: Chief complaint of right arm numbness, pain, difficulty speaking, asymmetry of lips at 2:30 in the afternoon following a vaccination of Influenza and Typhoid at 11:30am.  Patient was taken to hospital by EMS.
Age: 50.0
Sex: M
Vaccine: FLU3, TYP, FLUX, TYP
Symptoms: Malaise, Pain, Paraesthesia, Paralysis, Somnolence
Clinical narrative: Chief complaint of right arm numbness, pain, difficulty speaking, asymmetry of lips at 2:30 in the afternoon following a vaccination of Influenza and Typhoid at 11:30am.  Patient was taken to hospital by EMS.
Age: 0.56
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Aphasia, Autism, Catatonia, Coordination abnormal, Crying
Clinical narrative: Prolonged high pitch cry - 6 plus hrs. Post vaccinal encephalits. Patient diagnosed with autism in 2003. Motor incoordination, gross motor delay, Mom noticed a knocked knee stance and also with ambulation along with his feet pointing out around this time, falls more often then other children, extra bulge on inside of his knees with standing. In standing patient had a tendency to rotate his feet with some pronation and stood with his knees in valgus and hyperextened position. However, this was not constant but intermittent throughout evaluation. Increase in muscle mass which looked like it was in the medial side of the knee. This may be indicative of an umbalance muscle activation with the Vmo being more activated the VL. Gait abnormal. Patient has been diagnosed with autism. Everytime he has received immunizations, he has regressed in development milestones. After the above immunization he lost speech milestones and became catatonic. He is making some progress ent very slowly.
Age: 0.56
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Encephalitis, Fall, Gait disturbance, High-pitched crying, Hypokinesia
Clinical narrative: Prolonged high pitch cry - 6 plus hrs. Post vaccinal encephalits. Patient diagnosed with autism in 2003. Motor incoordination, gross motor delay, Mom noticed a knocked knee stance and also with ambulation along with his feet pointing out around this time, falls more often then other children, extra bulge on inside of his knees with standing. In standing patient had a tendency to rotate his feet with some pronation and stood with his knees in valgus and hyperextened position. However, this was not constant but intermittent throughout evaluation. Increase in muscle mass which looked like it was in the medial side of the knee. This may be indicative of an umbalance muscle activation with the Vmo being more activated the VL. Gait abnormal. Patient has been diagnosed with autism. Everytime he has received immunizations, he has regressed in development milestones. After the above immunization he lost speech milestones and became catatonic. He is making some progress ent very slowly.
Age: 0.56
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Muscle disorder
Clinical narrative: Prolonged high pitch cry - 6 plus hrs. Post vaccinal encephalits. Patient diagnosed with autism in 2003. Motor incoordination, gross motor delay, Mom noticed a knocked knee stance and also with ambulation along with his feet pointing out around this time, falls more often then other children, extra bulge on inside of his knees with standing. In standing patient had a tendency to rotate his feet with some pronation and stood with his knees in valgus and hyperextened position. However, this was not constant but intermittent throughout evaluation. Increase in muscle mass which looked like it was in the medial side of the knee. This may be indicative of an umbalance muscle activation with the Vmo being more activated the VL. Gait abnormal. Patient has been diagnosed with autism. Everytime he has received immunizations, he has regressed in development milestones. After the above immunization he lost speech milestones and became catatonic. He is making some progress ent very slowly.
Age: 0.56
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Autism, Oral intake reduced, Sensory disturbance, Speech disorder
Clinical narrative: Prolonged high pitch cry - 6 plus hrs. Post vaccinal encephalits. Patient diagnosed with autism in 2003. Motor incoordination, gross motor delay, Mom noticed a knocked knee stance and also with ambulation along with his feet pointing out around this time, falls more often then other children, extra bulge on inside of his knees with standing. In standing patient had a tendency to rotate his feet with some pronation and stood with his knees in valgus and hyperextened position. However, this was not constant but intermittent throughout evaluation. Increase in muscle mass which looked like it was in the medial side of the knee. This may be indicative of an umbalance muscle activation with the Vmo being more activated the VL. Gait abnormal. Patient has been diagnosed with autism. Everytime he has received immunizations, he has regressed in development milestones. After the above immunization he lost speech milestones and became catatonic. He is making some progress ent very slowly.
Age: 2.0
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Aphasia, Autism, Catatonia, Coordination abnormal, Crying
Clinical narrative: Reduced food intake, loss of words, sensory issues, perseveration, Continues to receive wrap around services, occupational therapy, speech therapy, Is on casein free/gluten free diet.  Take nutriental, mineral, vitamin and enzemnatic supplements.
Age: 2.0
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Encephalitis, Fall, Gait disturbance, High-pitched crying, Hypokinesia
Clinical narrative: Reduced food intake, loss of words, sensory issues, perseveration, Continues to receive wrap around services, occupational therapy, speech therapy, Is on casein free/gluten free diet.  Take nutriental, mineral, vitamin and enzemnatic supplements.
Age: 2.0
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Muscle disorder
Clinical narrative: Reduced food intake, loss of words, sensory issues, perseveration, Continues to receive wrap around services, occupational therapy, speech therapy, Is on casein free/gluten free diet.  Take nutriental, mineral, vitamin and enzemnatic supplements.
Age: 2.0
Sex: M
Vaccine: DTAP, HEP, HIBV, DTAP, HIBV
Symptoms: Autism, Oral intake reduced, Sensory disturbance, Speech disorder
Clinical narrative: Reduced food intake, loss of words, sensory issues, perseveration, Continues to receive wrap around services, occupational therapy, speech therapy, Is on casein free/gluten free diet.  Take nutriental, mineral, vitamin and enzemnatic supplements.
Age: 1.37
Sex: M
Vaccine: DTAPHEPBIP, IPV, PNC
Symptoms: Lethargy, Pyrexia, Respiratory syncytial virus infection, Swelling
Clinical narrative: Within two hours, high fever, > 102, and extreme lethargy, swelling in both legs where vaccines were administered. Swelling went away by next day, fever persisted, spiking up to over 102 repeatedly. Patient was seen in Emergency room, two days later came down with (nosocomial) rotavirus, probably exposed in ER. Patient has still not recovered from rotavirus.
Age: 0.73
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Injection site mass
Clinical narrative: This case was reported by a nurse and described the occurrence of injection site mass in a 8 month old female pt who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hep B recombinant and inactivated poliovirus vaccine combined (Pediarix). On 26May04 the pt received the 3rd dose of Pediarix (lot 21920A9). Approx 47 days later, on 12Jul04, the pt experienced an injection site reaction characterized as a knot at the injection site. The pt was treated two separate courses of with amoxicillin trihydrate and potassium clavulanate (Augmentin). The event resolved on 14Sep04. The nurse considered the event to possibly be related to vaccination with Pediarix.
Sex: F
Vaccine: ANTH
Symptoms: Body temperature increased, Injection site erythema, Injection site mass, Injection site swelling
Clinical narrative: Redness, swelling, huge bump, dizziness, hot body temperature
Age: 0.4
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, DTAPHEPBIP, HIBV, PNC, DTAPHEPBIP, HIBV, PNC
Symptoms: Tremor, Tremor neonatal
Clinical narrative: This case was reported by a consumer and described the occurrence of tremor in a 4 month old male pt who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hep B recombinant and inactivated poliovirus vaccine combined (Pediarix). The reporter is the mother of the pt. A physician or other health care professional has not verified this report. The reporter stated she felt, what appeared to be the baby experiencing tremors twice during the pregnancy. On 13Sep04, the pt received the second dose of Pediarix. On the same day, the pt also received injections of combination Haemophilus influenzae type b conjugate vaccine (Pedvax Hib), and 7 valent pneumococcal conjugate vaccine (Prevnar). Concurrently, the pt received acetaminophen (Tylenol). Approx 11 days after the administration of the second dose of Pediarix, on 24Sep04, the pt experienced shaking and tremors while nursing. The event lasted about 10 seconds. On 27Sep04, the pt experienced a tremor described as head shaking. The head shaking lasted a shorter period of time than the tremors on 24Sep04. On 02Oct04 the pt experienced a tremor in both his legs. The pt was seen at a physician's office. The event was ongoing at the time of initial reporting.
Age: 0.4
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, DTAPHEPBIP, HIBV, PNC, DTAPHEPBIP, HIBV, PNC
Symptoms: Tremor
Clinical narrative: This case was reported by a consumer and described the occurrence of tremor in a 4 month old male pt who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hep B recombinant and inactivated poliovirus vaccine combined (Pediarix). The reporter is the mother of the pt. A physician or other health care professional has not verified this report. The reporter stated she felt, what appeared to be the baby experiencing tremors twice during the pregnancy. On 13Sep04, the pt received the second dose of Pediarix. On the same day, the pt also received injections of combination Haemophilus influenzae type b conjugate vaccine (Pedvax Hib), and 7 valent pneumococcal conjugate vaccine (Prevnar). Concurrently, the pt received acetaminophen (Tylenol). Approx 11 days after the administration of the second dose of Pediarix, on 24Sep04, the pt experienced shaking and tremors while nursing. The event lasted about 10 seconds. On 27Sep04, the pt experienced a tremor described as head shaking. The head shaking lasted a shorter period of time than the tremors on 24Sep04. On 02Oct04 the pt experienced a tremor in both his legs. The pt was seen at a physician's office. The event was ongoing at the time of initial reporting.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Hair disorder, Injection site reaction
Clinical narrative: This case was reported by a nurse practitioner and described the occurrence of hair growth at the injection site in a 2 month old female pt who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hep B recombinant and inactivated poliovirus vaccine combined (Pediarix). On 25May04 the pt received the first dose of Pediarix (lot 21924A2) at .5ml. Approx 2 weeks later, in June 2004, the pt developed a patch of hair at the injection site. It was reported that the pt received other vaccines were not reported. The pt received her second dose of Pediarix on 15Sep04. The outcome of the event is unk.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Bacterial infection, Cough, Drug ineffective, Haemoptysis
Clinical narrative: This case was reported by a consumer and described the occurrence of pertussis in a 2 month old male patient who received diphtheria and tetanus toxoids and acellular pertussis absorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined. The reporter is the mother of the patient. A physician or other healthcare professional has not verified this report. The patient's past medical history included prematurity. On an unspecified date in 2004, the patient received the first dose of Pediarix. On the same date, the patient received other vaccines, but the consumer was unsure of the names. At an unspecified time following the first dose of Pediarix, at two months of age, on an unspecified date in August 2004, the patient was coughing up blood and phlegm and was seen at a physician's office. The patient was diagnosed with pertussis and was hospitalized. The consumer reported that the patient received the second dose of Pediarix while in the hospital. The events had improved as of the time of initial reporting.
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Irritability, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a female infant who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hep B recombinant and inactivated poliovirus vaccine combined (Pediarix). The nurse reported that the office she represented did not administer the Pediarix. On an unspecified date in 2004, the pt received a dose of Pediarix (dose number and lot number not provided). At an unspecified time following the administration of Pediarix, on an unspecified date in 2004, the pt developed a high fever and fussiness. The pt was seen at a physician's office. The events resolved on an unspecified date in 2004. The immunization series with Pediarix was discontinued. The nurse considered the events to possibly be related to immunization with Pediarix. Report initially received via manf.
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Crying, Pyrexia, Screaming
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a female infant who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hep B recombinant, and inactivated poliovirus vaccine combined (Pediarix). The nurse stated that many pt's experienced a fever following the receipt of Pediarix, however, only one identifiable pt was reported. On an unspecified date in 2004, the pt received the first dose of Pediarix. At an unspecified time following the first admin of Pediarix, on the same day, the pt experienced a fever. The fever resolved 24 hrs later. On an unspecified date in 2004, the pt received the second dose of Pediarix. At an unspecified time following the second dose administration of Pediarix, on the same day, the pt experienced a fever and screaming. The screaming resolved several hours later and the fever resolved 72 hrs later.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Injection site swelling
Clinical narrative: This case was reported by a physician and described the occurrence of injection site mass in a 4 month old female pt who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hep b recombinant and inactivated poliovirus vaccine combined (Pediarix). On 22Sep04 the pt received the 2nd dose of Pediarix (lot number not specified). On an unspecified date later in 2004, the pt's parents reported that their daughter had experienced an injection site reaction characterized as a small, raised bump at the injection site. No redness or swelling was noted around the injection site, and no other symptoms were reported. At the time of reporting, the event remained unresolved.
Age: 66.0
Sex: M
Vaccine: LYME
Symptoms: Obesity, Oedema
Clinical narrative: This case was reported by a consumer and described the occurrence of swelling of the big toe in a 66 year old male pt who received Lyme disease vaccine recombinant (Lymerix). A physician or other health care professional has not verified this report. Medical history was notable for a family history of gout. The pt stated that he used to weigh 300 pounds. He has been on a diet and as of 04Mar04, weighs 270 pounds after a year on the diet. The pt stated that he thinks he completed the Lymerix series in 1997. He did not state that he had been a clinical trial participant. Approx 7 years later, on an unspecified date in 2004, the pt experienced swelling of his big toe and subsequently, swelling of his entire foot. At the time of reporting, the pt had not seen a physician. The events were unresolved.
Age: 62.0
Sex: M
Vaccine: LYME
Symptoms: Arthritis, Drug ineffective, Viral infection
Clinical narrative: This case was reported by a consumer and described the occurrence of arthritis in a 62 year old male pt who received Lyme disease vaccine recombinant (Lymerix). A physician or other health care professional has not verified this report. The pt's past medical history included hay fever. Concurrent medications included Advil. On an unspecified date in Jul2002, the pt received the third dose of Lymerix. At an unspecified time following the third administration of Lymerix, the pt experienced arthritis. The pt also developed Lyme disease and did not respond to the vaccination series with Lymerix. The pt seen by a physician. The events were unresolved.
Age: 36.0
Sex: F
Vaccine: LYME
Symptoms: Blood creatine phosphokinase increased
Clinical narrative: This case was reported by a nurse and described the occurrence of elevated creatinine kinase in a 36 year old female pt who received Lyme disease vaccine recombinant (Lymerix). On an unspecified date the pt received a dose of Lymerix (dose number not specified). The nurse did not state that the pt had been a clinical trial participant. At an unspecified time after receiving the vaccination, in 2004, laboratory evaluations revealed an elevated creatinine kinase level. The nurse stated that, the pt does not have lab values prior to recent work up no way to know when creatinine kinase was first elevated. The outcome of the event is unk.
Age: 28.0
Sex: F
Vaccine: LYME
Symptoms: Asthenia, Fatigue, Injection site oedema, Injection site pain, Myalgia
Clinical narrative: This case was reported by a physical therapist, who was also the pt. The report described the occurrence of suspected Lyme disease in a 35 year old female who participated in a lyme disease vaccine clinical trial. It was subsequently confirmed that the pt received Lymerix disease vaccine (study vaccine 215274). According to the pt's report, she received the third dose of study vaccine on an unspecified date in 1992. On an unspecified date in 2004, the pt began to experience signs and symptoms of Lyme disease, specifically weakness and fatigue. The events persisted as of 29Apr04. Review of clinical trial records revealed the following information. At the time of study enrollment on 16Feb95, the pt reported no relevant medical history of concurrent conditions. Concurrent medications included Levonorgestrel + ethinyl estradiol (Triphasil) for contraception. On 16Feb95, the pt received the first dose of Lyme disease vaccine IM in the left deltoid muscle. Later that day, at an unspecified time post immunization, she developed an injection site reaction characterized by soreness and slight swelling. The injection site reaction resolved without treatment on 18Feb95. It was recorded in the clinical trial documents as mild severity and related to study vaccine administration. On 12Mar95, the pt developed an ear infection, which was treated with ciprofloxacin and resolved on 17Mar95. This event was recorded in the clinical trial documents as mild in severity and unrelated to study vaccine administration. The injection site reaction and ear infection were reported to the IND and therefore, are not listed as adverse events in this report. On 15Mar95, while still receiving ciprofloxacin therapy for the treatment of an ear infection, the pt received the second dose of Lyme disease vaccine IM in the left deltoid muscle. Later that day, at an unspecified time post immunization, she experienced soreness at the injection site and achiness in her left arm. The events were treated with ibuprofen and resolved on 22Mar95. They were recorded in the clinical trial documents as mild in severity and related to study vaccine admin. These events were reported to the IND and, therefore, are not listed as adverse events in this report. On 10Apr96, the pt received the third dose of Lyme disease vaccine IM in the left deltoid. No adverse experiences were recorded in the clinical trial documents following this dose of vaccine. The pt's last study visit occurred on 19Oct96.
Age: 28.0
Sex: F
Vaccine: LYME
Symptoms: Otitis media, Vaccine positive rechallenge
Clinical narrative: This case was reported by a physical therapist, who was also the pt. The report described the occurrence of suspected Lyme disease in a 35 year old female who participated in a lyme disease vaccine clinical trial. It was subsequently confirmed that the pt received Lymerix disease vaccine (study vaccine 215274). According to the pt's report, she received the third dose of study vaccine on an unspecified date in 1992. On an unspecified date in 2004, the pt began to experience signs and symptoms of Lyme disease, specifically weakness and fatigue. The events persisted as of 29Apr04. Review of clinical trial records revealed the following information. At the time of study enrollment on 16Feb95, the pt reported no relevant medical history of concurrent conditions. Concurrent medications included Levonorgestrel + ethinyl estradiol (Triphasil) for contraception. On 16Feb95, the pt received the first dose of Lyme disease vaccine IM in the left deltoid muscle. Later that day, at an unspecified time post immunization, she developed an injection site reaction characterized by soreness and slight swelling. The injection site reaction resolved without treatment on 18Feb95. It was recorded in the clinical trial documents as mild severity and related to study vaccine administration. On 12Mar95, the pt developed an ear infection, which was treated with ciprofloxacin and resolved on 17Mar95. This event was recorded in the clinical trial documents as mild in severity and unrelated to study vaccine administration. The injection site reaction and ear infection were reported to the IND and therefore, are not listed as adverse events in this report. On 15Mar95, while still receiving ciprofloxacin therapy for the treatment of an ear infection, the pt received the second dose of Lyme disease vaccine IM in the left deltoid muscle. Later that day, at an unspecified time post immunization, she experienced soreness at the injection site and achiness in her left arm. The events were treated with ibuprofen and resolved on 22Mar95. They were recorded in the clinical trial documents as mild in severity and related to study vaccine admin. These events were reported to the IND and, therefore, are not listed as adverse events in this report. On 10Apr96, the pt received the third dose of Lyme disease vaccine IM in the left deltoid. No adverse experiences were recorded in the clinical trial documents following this dose of vaccine. The pt's last study visit occurred on 19Oct96.
Sex: F
Vaccine: LYME
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: This case was reported by a consumer and described the occurrence of tingling extremities in an adult female pt who received Lyme disease vaccine recombinant (Lymerix). A physician or other health care professional has not verified this report. On an unspecified date in 2002, the pt received a dose of Lymerix (dose number not specified). At an unspecified number of months following the admin of Lymerix in Apr2004, the pt experienced tingling and numbness of her hands, feet, arms, and legs. The pt was see at a physician's office. The events were unresolved. The pt declined to grant authorization for man to contact her physician.
Sex: M
Vaccine: LYME
Symptoms: Arthritis
Clinical narrative: This case was reported by a physician's assistant and described the occurrence of arthritis in an adult male pt who received Lyme disease vaccine recombinant (Lymerix). On an unspecified date, the pt received a dose of Lymerix (dose number not specified).  Several years after the pt received the Lymerix vaccine series, on an unspecified date in 2004, the pt developed arthritis and was seen at a physician's office. At the time of reporting, the event was unresolved. The physician's assistant considered the arthritis to possibly be related to vaccination with Lymerix.
Sex: M
Vaccine: LYME
Symptoms: Drug ineffective, Rash, Viral infection
Clinical narrative: This case was reported by a consumer and described the occurrence of rash in an adult male pt who received Lyme disease vaccine recombinant (Lymerix). A physician or other health care professional has not verified this report. The reporter is the pt. On an unspecified date in 1999, the pt received the second dose of Lymerix. The pt reported that he never received the third dose of Lymerix. Approx 5 years after the second dose of Lymerix, on 12Jul04, the pt experienced rash on his leg. The  pt reported that the rash does not itch and that he suspects it may be Lyme disease. The event was ongoing at the time of initial reporting.
Age: 50.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia
Clinical narrative: This case was initially reported by a consumer and described the occurrence of knee joint pain in a 50 year old female pt who received Lyme disease vaccine recombinant (Lymerix). The initial reporter is the pt. Follow up information was received by a physician. Concurrent medication at the time of immunization included Thyroxine sodium (Levoxyl). The indication for Levoxyl was not specified. The consumer reported that on an unspecified date in 2000, the pt received the third dose of Lymerix in the right arm. Approx four years after the admin of Lymerix, on an unspecified date in April 2004, the pt experienced joint pain in both knees. The pt was seen at a physician's office. The event was ongoing at the time of initial reporting. The physician subsequently reported that he examined the patient on 1/19/04. The physician stated that the patient experienced swelling likely secondary to MRI dye. He also stated "No report of reaction to Lyme disease."
Age: 55.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Gait disturbance
Clinical narrative: This case was reported by a consumer and described the occurrence of knee joint pain in a 55 year old male pt who received Lyme disease vaccine recombinant (Lymerix). The reporter is the pt. A physician or other health care professional has not verified this report. The pt's medical history was notable for no drug allergies. Concurrent medication at the time of immunization included Atorvastatin calcium (Lipitor). On an unspecified date in 2000, the pt received the third dose of Lymerix. Approx four years after the administration of Lymerix, on an unspecified date in late spring 2004, the pt experienced joint pain in the knee. The pt reported that he experienced so much pain that he limped. The pt was seen at a physicians office and underwent "multiple tests"; however, no tests or test results were reported. At the time of initial reporting, the knee pain was worsening.
Age: 52.0
Sex: M
Vaccine: LYME
Symptoms: Drug ineffective, Laboratory test abnormal, Viral infection
Clinical narrative: This case was reported by a physician and described the occurrence of Lyme disease symptoms in a 52 year old male pt who received Lyme disease vaccine recombinant (Lymerix). On an unspecified date in 2002, the pt received the second dose of Lymerix. Approx two years after the admin of the second dose of Lymerix, on 06Aug04, the pt was seen by the reporting physician. The reporting physician stated that, the pt presented with Lyme disease symptoms. The reporting physician also stated the following lab results, Igm ELISA test was positive and the western blot was negative. The event was ongoing at the time of initial reporting.
Age: 19.0
Sex: F
Vaccine: LYME
Symptoms: Amnesia, Arthralgia, Disturbance in attention, Fatigue, Gait disturbance
Clinical narrative: This case was reported by a lawyer and described the occurrence of short term memory loss in a 19 year old female pt who received Lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced migraine headache, fatigue, loss of short term memory, poor concentration, balance problems, joint pain and a positive SPECT (single photon emission computerized tomography) scan. Time to onset, treatment and outcome were not reported.
Age: 19.0
Sex: F
Vaccine: LYME
Symptoms: Laboratory test abnormal, Migraine
Clinical narrative: This case was reported by a lawyer and described the occurrence of short term memory loss in a 19 year old female pt who received Lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced migraine headache, fatigue, loss of short term memory, poor concentration, balance problems, joint pain and a positive SPECT (single photon emission computerized tomography) scan. Time to onset, treatment and outcome were not reported.
Age: 52.0
Sex: F
Vaccine: LYME
Symptoms: Cognitive disorder, Fibromyalgia, Hypoaesthesia, Laboratory test abnormal, Nervous system disorder
Clinical narrative: This case was reported by a lawyer and described the occurrence of fibromyalgia type symptoms in a 52 year old female pt who received Lymerix injection. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fibromyalgia type symptoms along with neurologic symptoms including cognitive deficits, numbness and tingling with decreased perfusion on her SPECT (single photon emission computerized tomography) scan. Time to onset, treatment, and outcome were not reported.
Age: 52.0
Sex: F
Vaccine: LYME
Symptoms: Paraesthesia
Clinical narrative: This case was reported by a lawyer and described the occurrence of fibromyalgia type symptoms in a 52 year old female pt who received Lymerix injection. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fibromyalgia type symptoms along with neurologic symptoms including cognitive deficits, numbness and tingling with decreased perfusion on her SPECT (single photon emission computerized tomography) scan. Time to onset, treatment, and outcome were not reported.
Age: 17.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Cognitive disorder, Disturbance in attention, Dizziness, Fatigue
Clinical narrative: This case was reported by a lawyer and described the occurrence of loss of concentration in a 17 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fatigue, migraine headaches, myalgias, arthralgias, dizziness, gait disturbances, insomnia, numbness, loss of concentration, cognitive problems and fibromyalgia type symptoms with a SPECT (single photon emission computerized tomography) scan showing focally diminished cortical brain activity. Time to onset, treatment, and outcome were not reported.
Age: 17.0
Sex: F
Vaccine: LYME
Symptoms: Fibromyalgia, Gait disturbance, Headache, Hypoaesthesia, Insomnia
Clinical narrative: This case was reported by a lawyer and described the occurrence of loss of concentration in a 17 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fatigue, migraine headaches, myalgias, arthralgias, dizziness, gait disturbances, insomnia, numbness, loss of concentration, cognitive problems and fibromyalgia type symptoms with a SPECT (single photon emission computerized tomography) scan showing focally diminished cortical brain activity. Time to onset, treatment, and outcome were not reported.
Age: 17.0
Sex: F
Vaccine: LYME
Symptoms: Laboratory test abnormal, Migraine, Myalgia
Clinical narrative: This case was reported by a lawyer and described the occurrence of loss of concentration in a 17 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fatigue, migraine headaches, myalgias, arthralgias, dizziness, gait disturbances, insomnia, numbness, loss of concentration, cognitive problems and fibromyalgia type symptoms with a SPECT (single photon emission computerized tomography) scan showing focally diminished cortical brain activity. Time to onset, treatment, and outcome were not reported.
Age: 61.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Laboratory test abnormal, Nervous system disorder
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 61 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced joint pain, clawing and other neurologic complaints and abnormal MRI (magnetic resonance imaging scan).  Time to onset, treatment, and outcome were not reported.
Age: 42.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Disturbance in attention, Headache, Muscle twitching, Nervous system disorder
Clinical narrative: This case was reported by a lawyer and described the occurrence of loss of concentration in a 42 year old female pt who received Lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix.  At an unk time after receiving Lymerix, the pt experienced tingling, burning, joint pain and muscle twitching, loss of concentration, paresthesias, headaches, and other neurological symptoms. Time to onset, treatment, and outcome were not reported.
Age: 42.0
Sex: F
Vaccine: LYME
Symptoms: Paraesthesia, Skin burning sensation
Clinical narrative: This case was reported by a lawyer and described the occurrence of loss of concentration in a 42 year old female pt who received Lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix.  At an unk time after receiving Lymerix, the pt experienced tingling, burning, joint pain and muscle twitching, loss of concentration, paresthesias, headaches, and other neurological symptoms. Time to onset, treatment, and outcome were not reported.
Age: 28.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Fatigue, Headache, Nervous system disorder, Paraesthesia
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 28 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced joint pain, tingling, fatigue, headaches, and multiple neurologic complaints.  Time to onset, treatment, and outcome were not reported.
Age: 17.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Disturbance in attention, Fatigue, Headache
Clinical narrative: This case was reported by a lawyer and described the occurrence of loss of concentration in a 17 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fatigue,arthralgias, headaches, and loss of concentration. Time to onset, treatment, and outcome were not reported.
Age: 53.0
Sex: F
Vaccine: LYME
Symptoms: Amnesia, Arthralgia, Fatigue, Insomnia
Clinical narrative: This case was reported by a lawyer and described the occurrence of loss of concentration in a 53 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced severe joint pain, insomnia, fatigue, and memory loss.  Time to onset, treatment, and outcome were not reported.
Age: 33.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 33 year old female who received lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the pateint experieced "severe joint pain". Time to onset, treatment, and outcome were not reported.
Age: 53.0
Sex: M
Vaccine: LYME, LYME
Symptoms: Arthralgia, Fatigue, Skin burning sensation
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 53 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain", fatigue, and burning, stabbing, pain". Time to onset, treatment, and outcome were not reported.
Age: 53.0
Sex: M
Vaccine: LYME, LYME
Symptoms: Alanine aminotransferase increased, Arthralgia, Arthritis, Aspartate aminotransferase increased, Blood bilirubin increased
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 53 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain", fatigue, and burning, stabbing, pain". Time to onset, treatment, and outcome were not reported.
Age: 53.0
Sex: M
Vaccine: LYME, LYME
Symptoms: Blood cholesterol increased, Blood triglycerides increased, Condition aggravated, Fatigue, Hypoaesthesia
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 53 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain", fatigue, and burning, stabbing, pain". Time to onset, treatment, and outcome were not reported.
Age: 53.0
Sex: M
Vaccine: LYME, LYME
Symptoms: Joint swelling, Laboratory test abnormal, Liver function test abnormal, Neck pain, Neuropathy
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 53 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain", fatigue, and burning, stabbing, pain". Time to onset, treatment, and outcome were not reported.
Age: 53.0
Sex: M
Vaccine: LYME, LYME
Symptoms: Pain, Pain in jaw, Paraesthesia
Clinical narrative: This case was reported by a lawyer and described the occurrence of joint pain in a 53 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain", fatigue, and burning, stabbing, pain". Time to onset, treatment, and outcome were not reported.
Age: 58.0
Sex: M
Vaccine: LYME
Symptoms: Amnesia, Arthralgia, Confusional state, Fatigue, Fibromyalgia
Clinical narrative: This case was reported by a lawyer and described the occurrence of short term memory loss in a 58 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain, fatigue, tingling, mental confusion, short term memory loss, and fibromyalgia type symptoms" time to onset, treatment, and outcome were not reported.
Age: 58.0
Sex: M
Vaccine: LYME
Symptoms: Paraesthesia
Clinical narrative: This case was reported by a lawyer and described the occurrence of short term memory loss in a 58 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain, fatigue, tingling, mental confusion, short term memory loss, and fibromyalgia type symptoms" time to onset, treatment, and outcome were not reported.
Age: 43.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Asthenia, Confusional state, Disturbance in attention, Fatigue
Clinical narrative: This case was reported by a lawyer and described the occurrence of confusion in a 43 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspeceified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain, fatigue, numbness, burning, weakness, confusion, loss of concentration, and headaches" time to onset, treatment, and outcome were not reported.
Age: 43.0
Sex: M
Vaccine: LYME
Symptoms: Headache, Hypoaesthesia, Skin burning sensation
Clinical narrative: This case was reported by a lawyer and described the occurrence of confusion in a 43 year old male patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspeceified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "severe joint pain, fatigue, numbness, burning, weakness, confusion, loss of concentration, and headaches" time to onset, treatment, and outcome were not reported.
Age: 56.0
Sex: M
Vaccine: LYME
Symptoms: Amnesia, Arthralgia, Confusional state, Disorientation, Disturbance in attention
Clinical narrative: This case was reported by a lawyer and described the occurrence of memory loss in a 56 year old male patient who received Lyme disease vaccine recombinant OpsA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "joint pain, fatigue, tingling, memory loss, gait disturbance, disorientation, loss of concentration, peripheral neuropathy and confusion" Time to onset, treatmet and outcome were not reported.
Age: 56.0
Sex: M
Vaccine: LYME
Symptoms: Fatigue, Gait disturbance, Neuropathy peripheral, Paraesthesia
Clinical narrative: This case was reported by a lawyer and described the occurrence of memory loss in a 56 year old male patient who received Lyme disease vaccine recombinant OpsA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "joint pain, fatigue, tingling, memory loss, gait disturbance, disorientation, loss of concentration, peripheral neuropathy and confusion" Time to onset, treatmet and outcome were not reported.
Age: 42.0
Sex: F
Vaccine: LYME
Symptoms: Nervous system disorder
Clinical narrative: This case was reported by a lawyer and described the occurrence of neurological complications on in a 42 year old female patient who received Lyme disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient receieved LYMErix. At an unknown time after receiving LYMErix, the patient experienced "neurologic complication". Time to onset, treatment, and outcome were not reported.
Age: 75.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Nervous system disorder
Clinical narrative: This case was reported by a lawyer and described the occurrence of rheumatologic complications in a 75 year old male patinet who received LYME disease vaccine recombinant OspA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time later after receiving LYMErix, the patient experienced "rheumatologic and neurologic complications". Time to onset, treatment, and outcome were not reported.
Age: 51.0
Sex: M
Vaccine: LYME
Symptoms: Arthropathy, Neuropathy peripheral
Clinical narrative: This case was reported by a lawyer and described the occurrence of peripheral neuropathy in a 51 year old male patinent who receieved LYME disease vaccine for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receieving LYMErix, the patient experience "rheumatologic and neurologic complaints including peripheral neuropathy" Time to onset, treatment and outcome were not reported.